Literature DB >> 9082583

[Radiotherapy in the early stage of Dupuytren's disease. The indications, technic and long-term results].

L Keilholz1, M H Seegenschmiedt, A D Born, R Sauer.   

Abstract

AIM: Radiotherapy was applied in our clinic to prevent the disease progression in early stage Dupuytren's contracture. Initial response, long-term outcome, acute and late toxicity of the treatment were evaluated in a retrospective analysis. PATIENTS AND
METHOD: Between 1982 and 1993, 96 patients (142 hands) received orthovoltage radiotherapy, which consisted of 2 radiotherapy courses with daily fractionation of 5 x 3 Gy (total dose: 30 Gy) separated by a 6 weeks interval. The Dupuytren's contracture was staged according to the classification of Tubiana et al. [38]. The initial evaluation was performed 3 months after completion of radiotherapy, while long-term outcome was analysed at last follow-up between February and April 1994. The mean follow-up was 6 +/- 2 (range 1 to 12) years. Fifty-seven patients with a follow-up of > or = 5 (median 7,5; mean 9,5 to 12) years were separately evaluated for long-term outcome, i.e. prevention of disease progression. Acute and late treatment toxicity was assessed using the RTOG/EORTC criteria.
RESULTS: According to stage, 130 (92%) cases remained stable at 3 months follow-up, 10(7%) improved and 2 (1%) progressed. An objective reduction of symptomatic cords and nodules was achieved in 107 (75%) cases at 3 months follow-up. Moreover, 87% of the patients reported a subjective relief of symptoms. In long-term follow-up, only 16 of 142 (11%) cases had progressed according to stage. In the group with a minimum follow-up of 5 years (n = 57), 44 (77%) patients experienced no progression, while 13 (23%) progressed inside (8 cases) or outside (5 cases) of the radiotherapy field. Many "failures" could have been avoided with appropriate choice of larger safety margins included in the treated portals, however, most failures were successfully managed by a second radiotherapy or hand surgery.
CONCLUSION: Radiotherapy prevents disease progression for early stage Dupuytren's contracture. Thus, an otherwise necessary surgical procedure in advanced stages of Dupuytren's contracture can be avoided. Moreover, in case of disease progression despite radiotherapy a second radiotherapy or salvage operation is still feasible.

Entities:  

Mesh:

Year:  1997        PMID: 9082583     DOI: 10.1007/bf03039191

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  24 in total

1.  Dupuytren's contracture.

Authors:  R FINNEY
Journal:  Br J Radiol       Date:  1955-11       Impact factor: 3.039

Review 2.  Dupuytren's disease.

Authors:  J W Strickland; R S Idler; J C Creighton
Journal:  Indiana Med       Date:  1990-06

3.  The fibromatoses: a clinicopathologic classification based on 140 cases.

Authors:  P W Allen
Journal:  Am J Surg Pathol       Date:  1977-09       Impact factor: 6.394

4.  Dupuytren's contracture and occupation.

Authors:  J T Hueston
Journal:  J Hand Surg Am       Date:  1987-09       Impact factor: 2.230

Review 5.  Therapeutic effects of low radiation doses.

Authors:  K R Trott
Journal:  Strahlenther Onkol       Date:  1994-01       Impact factor: 3.621

6.  [Radiotherapy of Dupuytren's contracture].

Authors:  A H Köhler
Journal:  Radiobiol Radiother (Berl)       Date:  1984

7.  Fasciectomy and Dupuytren's disease: a comparison between the open-palm technique and wound closure.

Authors:  J D Lubahn; G D Lister; T Wolfe
Journal:  J Hand Surg Am       Date:  1984-01       Impact factor: 2.230

8.  [Dupuytren's contracture].

Authors:  W Schink
Journal:  Med Klin       Date:  1978-10-06

9.  Dupuytren's contracture--a survey of a hospital population.

Authors:  D Rafter; R Kenny; M Gilmore; C H Walsh
Journal:  Ir Med J       Date:  1980-06

10.  [Dupuytren's contracture. Radiotherapy in the early stages].

Authors:  M Herbst; G Regler
Journal:  Strahlentherapie       Date:  1985-03
View more
  5 in total

1.  DEGRO guidelines for the radiotherapy of non-malignant disorders : part III: hyperproliferative disorders.

Authors:  M Heinrich Seegenschmiedt; Oliver Micke; Marcus Niewald; Ralph Mücke; Hans Theodor Eich; Jan Kriz; Reinhard Heyd
Journal:  Strahlenther Onkol       Date:  2015-03-10       Impact factor: 3.621

2.  Radiotherapy in early-stage Dupuytren's contracture. Long-term results after 13 years.

Authors:  Nicolas Betz; Oliver J Ott; Boris Adamietz; Rolf Sauer; Rainer Fietkau; Ludwig Keilholz
Journal:  Strahlenther Onkol       Date:  2010-01-28       Impact factor: 3.621

Review 3.  Dupuytren's Disease-Etiology and Treatment.

Authors:  Mike Ruettermann; Robert Michael Hermann; Karl Khatib-Chahidi; Paul M N Werker
Journal:  Dtsch Arztebl Int       Date:  2021-11-19       Impact factor: 8.251

4.  Recent Surgical and Medical Advances in the Treatment of Dupuytren's Disease - A Systematic Review of the Literature.

Authors:  Mafi R; Hindocha S; Khan W
Journal:  Open Orthop J       Date:  2012-02-23

Review 5.  Radiotherapy for non-malignant disorders: state of the art and update of the evidence-based practice guidelines.

Authors:  M H Seegenschmiedt; O Micke; R Muecke
Journal:  Br J Radiol       Date:  2015-05-08       Impact factor: 3.039

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.